Profound Medical (PROF) EBT Margin (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 465.00 |
| Dec 31, 2025 | 1,220.00 |
| Sep 30, 2025 | 55,843.00 |
| Jun 30, 2025 | -29,937.00 |
| Mar 31, 2025 | -96,078.00 |
| Dec 31, 2024 | 91,463.00 |
| Sep 30, 2024 | -815.00 |
| Jun 30, 2024 | 10,153.00 |
| Mar 31, 2024 | 644,362.00 |
| Dec 31, 2023 | -721,940.00 |
| Sep 30, 2023 | -13,598.00 |
| Jun 30, 2023 | 9,709.00 |
| Mar 31, 2023 | -102,738.00 |
| Dec 31, 2022 | 114,334.00 |
| Sep 30, 2022 | -4,817.00 |
| Jun 30, 2022 | -30,795.00 |
| Mar 31, 2022 | 570,982.00 |
| Dec 31, 2021 | -534,411.00 |
| Sep 30, 2021 | -3,164.00 |
| Jun 30, 2021 | -78,498.00 |
| Mar 31, 2021 | 30,171.00 |
| Dec 31, 2020 | 48,441.00 |
| Sep 30, 2020 | -23,862.00 |
| Jun 30, 2020 | 28,005.00 |
| Mar 31, 2020 | 117,098.00 |
| Dec 31, 2019 | -186,083.00 |
| Sep 30, 2019 | -10,121.00 |
| Jun 30, 2019 | 81,841.00 |